-
International Journal of Nephrology and Renovascular Disease
-
About Dovepress
Open access peer-reviewed scientific and medical journals.
-
Open Access
Dove Medical Press is now a member of the Open Access Initiative
-
An Author's Guide
A guide to help authors get their paper published.
-
Advocacy
Support Open Access and Dove Press
-
Reprints
Promotional Article Monitoring - further details
-
Favored Author Program
Real benefits for authors, including fast-track processing of papers.
Hypernatremia in a patient treated with sodium polystyrene sulfonate
Case report
(1867) Views (334) Full article downloads
Authors: Manish Nepal, Ion Dan Bucaloiu, Evan R Norfolk
Published Date November 2010
Volume 2010:3 Pages 141 - 143
DOI: http://dx.doi.org/10.2147/IJNRD.S13871
Manish Nepal, Ion Dan Bucaloiu, Evan R Norfolk
Geisinger Medical Center, Department of Nephrology, Danville, PA, USA
Abstract: Severe hyperkalemia requires urgent medical attention and correction in order to prevent arrhythmic complications. Sodium polystyrene sulfonate (SPS) is a cation exchange resin commonly used in the management of hyperkalemia. A recent review raised concerns regarding its effectiveness and potential adverse effects. Hypernatremia in adults in the setting of sodium polystyrene sulfonate therapy has not been described in the literature. We report the case of a woman who developed hypernatremia in the setting of excessive SPS administration and hope to increase awareness among clinicians regarding this potential side effect of SPS therapy.
Keywords: SPS, hyperkalemia
Readers of this article also read:
Update on the diagnosis and management of acute kidney injury
New and improved strategies for the treatment of gout
Perception of risk and benefit in patient-centered communication and care
The relationship between deliberate self-harm behavior, body dissatisfaction, and suicide in adolescents: current concepts
Zinc oxide nanoparticles as selective killers of proliferating cells
Active renin mass concentration to determine aldosterone-to-renin ratio in screening for primary aldosteronism
Cumulative clinical experience from over a decade of use of levofloxacin in community-acquired pneumonia: critical appraisal and role in therapy
Fat-free weight prediction in morbidly obese females
Methoxy polyethylene glycol-epoetin beta for anemia with chronic kidney disease
- Testimonials
"You do a tremendous job!!" Ruben Restrepo, The University of Texas Health Science Center at San Antonio
- Treatment of secondary hyperparathyroidism in kidney disease: what we know and do not know about use of calcimimetics and vitamin D analogs
- Potential renovascular hypertension, space missions, and the role of magnesium
- The use of everolimus in renal-transplant patients
- Management of hyperphosphatemia in patients with end-stage renal disease: focus on lanthanum carbonate




